140 related articles for article (PubMed ID: 38506544)
1. Reply to "Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence".
de Oliveira Correia ET; Purysko AS; Paranhos BM; Shoag JE; Padhani AR; Bittencourt LK
AJR Am J Roentgenol; 2024 Mar; ():1. PubMed ID: 38506544
[No Abstract] [Full Text] [Related]
2. Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence.
Takahashi T
AJR Am J Roentgenol; 2024 Mar; ():1. PubMed ID: 38506539
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness of multiparametric magnetic resonance imaging and MRI-guided biopsy in a population-based prostate cancer screening setting using a micro-simulation model.
Getaneh AM; Heijnsdijk EA; de Koning HJ
Cancer Med; 2021 Jun; 10(12):4046-4053. PubMed ID: 33991077
[TBL] [Abstract][Full Text] [Related]
4. Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial.
Wallström J; Geterud K; Kohestani K; Maier SE; Månsson M; Pihl CG; Socratous A; Arnsrud Godtman R; Hellström M; Hugosson J
Eur Radiol; 2021 Nov; 31(11):8692-8702. PubMed ID: 33890152
[TBL] [Abstract][Full Text] [Related]
5. Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography: The IP1-PROSTAGRAM Study.
Eldred-Evans D; Burak P; Connor MJ; Day E; Evans M; Fiorentino F; Gammon M; Hosking-Jervis F; Klimowska-Nassar N; McGuire W; Padhani AR; Prevost AT; Price D; Sokhi H; Tam H; Winkler M; Ahmed HU
JAMA Oncol; 2021 Mar; 7(3):395-402. PubMed ID: 33570542
[TBL] [Abstract][Full Text] [Related]
6. Repeated Prostate Cancer Screening Using Prostate-Specific Antigen Testing and Magnetic Resonance Imaging: A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial.
Nordström T; Annerstedt M; Glaessgen A; Carlsson S; Clements M; Abbadi A; Grönberg H; Jäderling F; Eklund M; Discacciati A
JAMA Netw Open; 2024 Feb; 7(2):e2354577. PubMed ID: 38324313
[TBL] [Abstract][Full Text] [Related]
7. Design of a magnetic resonance imaging-based screening program for early diagnosis of prostate cancer: preliminary results of a randomized controlled trial-Prostate Cancer Secondary Screening in Sapienza (PROSA).
Messina E; La Torre G; Pecoraro M; Pisciotti ML; Sciarra A; Poscia R; Catalano C; Panebianco V
Eur Radiol; 2024 Jan; 34(1):204-213. PubMed ID: 37561183
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer screening-stepping forward with MRI.
Padhani AR; Schoots IG
Eur Radiol; 2023 Oct; 33(10):6670-6676. PubMed ID: 37154952
[TBL] [Abstract][Full Text] [Related]
9. ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI.
Marsden T; Lomas DJ; McCartan N; Hadley J; Tuck S; Brown L; Haire A; Moss CL; Green S; Van Hemelrijck M; Coolen T; Santaolalla A; Isaac E; Brembilla G; Kopcke D; Giganti F; Sidhu H; Punwani S; Emberton M; Moore CM;
BMJ Open; 2021 Sep; 11(9):e048144. PubMed ID: 34593491
[TBL] [Abstract][Full Text] [Related]
10. Prostate Cancer Screening with Magnetic Resonance Imaging: Results from the Second Round of the Göteborg Prostate Cancer Screening 2 Trial.
Wallström J; Geterud K; Kohestani K; Maier SE; Pihl CG; Socratous A; Stranne J; Arnsrud-Godtman R; Månsson M; Hellström M; Hugosson J
Eur Urol Oncol; 2022 Feb; 5(1):54-60. PubMed ID: 34580053
[TBL] [Abstract][Full Text] [Related]
11. Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer.
Callender T; Emberton M; Morris S; Pharoah PDP; Pashayan N
JAMA Netw Open; 2021 Mar; 4(3):e2037657. PubMed ID: 33704474
[TBL] [Abstract][Full Text] [Related]
12. Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.
Grenabo Bergdahl A; Wilderäng U; Aus G; Carlsson S; Damber JE; Frånlund M; Geterud K; Khatami A; Socratous A; Stranne J; Hellström M; Hugosson J
Eur Urol; 2016 Oct; 70(4):566-573. PubMed ID: 26724840
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study.
Hao S; Discacciati A; Eklund M; Heintz E; Östensson E; Elfström KM; Clements MS; Nordström T
JAMA Oncol; 2022 Nov; 9(1):88-94. PubMed ID: 36355382
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
[TBL] [Abstract][Full Text] [Related]
15. An update on prostate biopsy in the era of magnetic resonance imaging.
Cicione A; De Nunzio C; Manno S; Damiano R; Posti A; Lima E; Tubaro A; Balloni F
Minerva Urol Nefrol; 2018 Jun; 70(3):264-274. PubMed ID: 29595039
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Prostate Cancer Found at Fifth Screening in the European Randomized Study of Screening for Prostate Cancer Rotterdam: Can We Selectively Detect High-grade Prostate Cancer with Upfront Multivariable Risk Stratification and Magnetic Resonance Imaging?
Alberts AR; Schoots IG; Bokhorst LP; Drost FH; van Leenders GJ; Krestin GP; Dwarkasing RS; Barentsz JO; Schröder FH; Bangma CH; Roobol MJ
Eur Urol; 2018 Mar; 73(3):343-350. PubMed ID: 28647216
[TBL] [Abstract][Full Text] [Related]
17. Prostate Cancers in the Prostate-specific Antigen Interval of 1.8-3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial.
Möller F; Månsson M; Wallström J; Hellström M; Hugosson J; Arnsrud Godtman R
Eur Urol; 2024 Mar; ():. PubMed ID: 38490856
[TBL] [Abstract][Full Text] [Related]
18. MRI as a screening tool for prostate cancer: current evidence and future challenges.
Würnschimmel C; Chandrasekar T; Hahn L; Esen T; Shariat SF; Tilki D
World J Urol; 2023 Apr; 41(4):921-928. PubMed ID: 35226140
[TBL] [Abstract][Full Text] [Related]
19. MRI Screening and MRI/US Fusion-Guided Transperineal Biopsy in Detecting Prostate Cancer.
Yin H; Shao J; Song H; Ding W; Xu B; Cao H; Wang J
Technol Cancer Res Treat; 2021; 20():15330338211019418. PubMed ID: 34013808
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
Boschheidgen M; Albers P; Schlemmer HP; Hellms S; Bonekamp D; Sauter A; Hadaschik B; Krilaviciute A; Radtke JP; Seibold P; Lakes J; Arsov C; Gschwend JE; Herkommer K; Makowski M; Kuczyk MA; Wacker F; Harke N; Debus J; Körber SA; Benner A; Kristiansen G; Giesel FL; Antoch G; Kaaks R; Becker N; Schimmöller L
Eur Urol; 2024 Feb; 85(2):105-111. PubMed ID: 37863727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
